United States (US) Drug Discovery Market (2025-2031) | Forecast, Share, Size & Revenue, Value, Segmentation, Trends, Industry, Competitive Landscape, Growth, Outlook, Analysis, Companies

Name: United States (US) Drug Discovery Market (2025-2031) | Forecast & Share
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Drug Type (Small Molecule Drugs, Biologic Drugs), By Technology (High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Other), By End User (Pharmaceutical Companies, Contract Research Organizations (CROs), Other) And Competitive Landscape

Product Code: ETC9964609	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Vasudha	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Drug Discovery Market Outlook
Market Size of United States (US) Drug Discovery Market, 2024
Forecast of United States (US) Drug Discovery Market, 2031
Historical Data and Forecast of United States (US) Drug Discovery Revenues & Volume for the Period 2021- 2031
United States (US) Drug Discovery Market Trend Evolution
United States (US) Drug Discovery Market Drivers and Challenges
United States (US) Drug Discovery Price Trends
United States (US) Drug Discovery Porter's Five Forces
United States (US) Drug Discovery Industry Life Cycle
Historical Data and Forecast of United States (US) Drug Discovery Market Revenues & Volume By Drug Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Drug Discovery Market Revenues & Volume By Small Molecule Drugs for the Period 2021- 2031
Historical Data and Forecast of United States (US) Drug Discovery Market Revenues & Volume By Biologic Drugs for the Period 2021- 2031
Historical Data and Forecast of United States (US) Drug Discovery Market Revenues & Volume By Technology for the Period 2021- 2031
Historical Data and Forecast of United States (US) Drug Discovery Market Revenues & Volume By High Throughput Screening for the Period 2021- 2031
Historical Data and Forecast of United States (US) Drug Discovery Market Revenues & Volume By Pharmacogenomics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Drug Discovery Market Revenues & Volume By Combinatorial Chemistry for the Period 2021- 2031
Historical Data and Forecast of United States (US) Drug Discovery Market Revenues & Volume By Nanotechnology for the Period 2021- 2031
Historical Data and Forecast of United States (US) Drug Discovery Market Revenues & Volume By Other for the Period 2021- 2031
Historical Data and Forecast of United States (US) Drug Discovery Market Revenues & Volume By End User for the Period 2021- 2031
Historical Data and Forecast of United States (US) Drug Discovery Market Revenues & Volume By Pharmaceutical Companies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Drug Discovery Market Revenues & Volume By Contract Research Organizations (CROs) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Drug Discovery Market Revenues & Volume By Other for the Period 2021- 2031
United States (US) Drug Discovery Import Export Trade Statistics
Market Opportunity Assessment By Drug Type
Market Opportunity Assessment By Technology
Market Opportunity Assessment By End User
United States (US) Drug Discovery Top Companies Market Share
United States (US) Drug Discovery Competitive Benchmarking By Technical and Operational Parameters
United States (US) Drug Discovery Company Profiles
United States (US) Drug Discovery Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Drug Discovery Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Drug Discovery Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Drug Discovery Market - Industry Life Cycle

3.4 United States (US) Drug Discovery Market - Porter's Five Forces

3.5 United States (US) Drug Discovery Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 United States (US) Drug Discovery Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.7 United States (US) Drug Discovery Market Revenues & Volume Share, By End User, 2021 & 2031F

4 United States (US) Drug Discovery Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investment in research and development by pharmaceutical companies

4.2.2 Technological advancements in drug discovery processes

4.2.3 Rising prevalence of chronic diseases driving the demand for new treatments

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval

4.3.2 High costs associated with drug discovery and development

4.3.3 Limited success rates in clinical trials leading to high attrition rates

5 United States (US) Drug Discovery Market Trends

6 United States (US) Drug Discovery Market, By Types

6.1 United States (US) Drug Discovery Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Drug Discovery Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 United States (US) Drug Discovery Market Revenues & Volume, By Small Molecule Drugs, 2021- 2031F

6.1.4 United States (US) Drug Discovery Market Revenues & Volume, By Biologic Drugs, 2021- 2031F

6.2 United States (US) Drug Discovery Market, By Technology

6.2.1 Overview and Analysis

6.2.2 United States (US) Drug Discovery Market Revenues & Volume, By High Throughput Screening, 2021- 2031F

6.2.3 United States (US) Drug Discovery Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F

6.2.4 United States (US) Drug Discovery Market Revenues & Volume, By Combinatorial Chemistry, 2021- 2031F

6.2.5 United States (US) Drug Discovery Market Revenues & Volume, By Nanotechnology, 2021- 2031F

6.2.6 United States (US) Drug Discovery Market Revenues & Volume, By Other, 2021- 2031F

6.3 United States (US) Drug Discovery Market, By End User

6.3.1 Overview and Analysis

6.3.2 United States (US) Drug Discovery Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F

6.3.3 United States (US) Drug Discovery Market Revenues & Volume, By Contract Research Organizations (CROs), 2021- 2031F

6.3.4 United States (US) Drug Discovery Market Revenues & Volume, By Other, 2021- 2031F

7 United States (US) Drug Discovery Market Import-Export Trade Statistics

7.1 United States (US) Drug Discovery Market Export to Major Countries

7.2 United States (US) Drug Discovery Market Imports from Major Countries

8 United States (US) Drug Discovery Market Key Performance Indicators

8.1 Research and development expenditure in the pharmaceutical industry

8.2 Number of patents filed for new drug discoveries

8.3 Success rate of drug candidates progressing from preclinical stages to clinical trials

9 United States (US) Drug Discovery Market - Opportunity Assessment

9.1 United States (US) Drug Discovery Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 United States (US) Drug Discovery Market Opportunity Assessment, By Technology, 2021 & 2031F

9.3 United States (US) Drug Discovery Market Opportunity Assessment, By End User, 2021 & 2031F

10 United States (US) Drug Discovery Market - Competitive Landscape

10.1 United States (US) Drug Discovery Market Revenue Share, By Companies, 2024

10.2 United States (US) Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Drug Discovery Market

Equatorial Guinea Drug Discovery Market

Eritrea Drug Discovery Market

Estonia Drug Discovery Market

Ethiopia Drug Discovery Market

Finland Drug Discovery Market

Global Drug Discovery Market

Middle East Drug Discovery Market

North America Drug Discovery Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here